id	sid	eid	entity	type
bptjm-56	1	1	berkeley pharma tech journal	ORG
bptjm-56	2	1	august 11	DATE
bptjm-56	2	2	2023	CARDINAL
bptjm-56	2	3	april 5	DATE
bptjm-56	2	4	2024	DATE
bptjm-56	2	5	2024	DATE
bptjm-56	2	6	4.0	CARDINAL
bptjm-56	2	7	one	CARDINAL
bptjm-56	7	1	rsv	ORG
bptjm-56	11	1	haily holston	PERSON
bptjm-56	11	2	avani karvat	PERSON
bptjm-56	11	3	simran lallian	PERSON
bptjm-56	11	4	pingju wu 1	PERSON
bptjm-56	12	1	1	CARDINAL
bptjm-56	12	2	36	CARDINAL
bptjm-56	12	3	2020,1	CARDINAL
bptjm-56	17	1	75%	PERCENT
bptjm-56	19	1	2	CARDINAL
bptjm-56	20	1	berkeley pharma tech journal	ORG
bptjm-56	20	2	61	CARDINAL
bptjm-56	23	1	two	CARDINAL
bptjm-56	23	2	tnf-ɑ	PERSON
bptjm-56	23	3	tgf	ORG
bptjm-56	23	4	1	CARDINAL
bptjm-56	23	5	2	DATE
bptjm-56	23	6	3	CARDINAL
bptjm-56	25	1	mia	PERSON
bptjm-56	25	2	il-17a	PRODUCT
bptjm-56	25	3	mia	PERSON
bptjm-56	25	4	mia	ORG
bptjm-56	26	1	berkeley pharma tech journal	ORG
bptjm-56	26	2	62	CARDINAL
bptjm-56	26	3	1	CARDINAL
bptjm-56	27	1	3	CARDINAL
bptjm-56	27	2	3.1	CARDINAL
bptjm-56	27	3	msc	PERSON
bptjm-56	27	4	secondly	ORDINAL
bptjm-56	27	5	berkeley pharma tech journal	ORG
bptjm-56	27	6	63	CARDINAL
bptjm-56	27	7	msc	PERSON
bptjm-56	29	1	37	CARDINAL
bptjm-56	29	2	ages 3-14 years old	DATE
bptjm-56	30	1	three	CARDINAL
bptjm-56	30	2	i/ii	EVENT
bptjm-56	30	3	14	CARDINAL
bptjm-56	31	1	9	CARDINAL
bptjm-56	31	2	9	CARDINAL
bptjm-56	32	1	fourteen	CARDINAL
bptjm-56	33	1	three	CARDINAL
bptjm-56	33	2	abc	ORG
bptjm-56	34	1	berkeley pharma tech journal	ORG
bptjm-56	34	2	64	DATE
bptjm-56	34	3	12	CARDINAL
bptjm-56	34	4	ages 4 to 9	DATE
bptjm-56	34	5	study.18	ORG
bptjm-56	34	6	third	ORDINAL
bptjm-56	34	7	two	CARDINAL
bptjm-56	34	8	three	CARDINAL
bptjm-56	34	9	2 month	DATE
bptjm-56	35	1	6-month	DATE
bptjm-56	35	2	12-month	DATE
bptjm-56	36	1	50%	PERCENT
bptjm-56	36	2	at least 2	CARDINAL
bptjm-56	37	1	the vineland adaptive	ORG
bptjm-56	39	1	manufactured.18	PERSON
bptjm-56	40	1	3.2	CARDINAL
bptjm-56	43	1	berkeley pharma tech journal	ORG
bptjm-56	43	2	65	CARDINAL
bptjm-56	43	3	2	CARDINAL
bptjm-56	45	1	2008	DATE
bptjm-56	46	1	10	CARDINAL
bptjm-56	46	2	two	CARDINAL
bptjm-56	47	1	berkeley pharma tech journal	ORG
bptjm-56	47	2	66	CARDINAL
bptjm-56	52	1	cntnap2	PRODUCT
bptjm-56	54	1	one	CARDINAL
bptjm-56	54	2	3-20 years old	DATE
bptjm-56	55	1	two	CARDINAL
bptjm-56	55	2	1	CARDINAL
bptjm-56	55	3	1	CARDINAL
bptjm-56	56	1	28 weeks	DATE
bptjm-56	56	2	week 16	DATE
bptjm-56	57	1	berkeley pharma tech journal	ORG
bptjm-56	57	2	67	CARDINAL
bptjm-56	58	1	the morning	TIME
bptjm-56	58	2	5-week	DATE
bptjm-56	59	1	one	CARDINAL
bptjm-56	60	1	3.3	CARDINAL
bptjm-56	60	2	sfn	PERSON
bptjm-56	60	3	2	CARDINAL
bptjm-56	60	4	nrf2	PERSON
bptjm-56	61	1	nrf2	PERSON
bptjm-56	61	2	ammation.29	PERSON
bptjm-56	61	3	nrf2	PERSON
bptjm-56	61	4	th17	PRODUCT
bptjm-56	62	1	sfn	CARDINAL
bptjm-56	63	1	one	CARDINAL
bptjm-56	63	2	singh	GPE
bptjm-56	63	3	29	CARDINAL
bptjm-56	63	4	18	CARDINAL
bptjm-56	63	5	berkeley pharma tech journal	ORG
bptjm-56	63	6	68	CARDINAL
bptjm-56	64	1	sfn	PERSON
bptjm-56	65	1	two	CARDINAL
bptjm-56	65	2	sfn	GPE
bptjm-56	66	1	60	CARDINAL
bptjm-56	67	1	sfn	GPE
bptjm-56	68	1	108	CARDINAL
bptjm-56	68	2	china	GPE
bptjm-56	68	3	sfn treatment.33	CARDINAL
bptjm-56	68	4	one-third	CARDINAL
bptjm-56	68	5	12 weeks	DATE
bptjm-56	69	1	10 years of age	DATE
bptjm-56	71	1	sfn	CARDINAL
bptjm-56	73	1	sfn	CARDINAL
bptjm-56	73	2	35	CARDINAL
bptjm-56	74	1	sfn	PERSON
bptjm-56	76	1	berkeley pharma tech journal	ORG
bptjm-56	76	2	69	CARDINAL
bptjm-56	76	3	three	CARDINAL
bptjm-56	76	4	markers.36	GPE
bptjm-56	79	1	sfn	CARDINAL
bptjm-56	80	1	sfn	PERSON
bptjm-56	81	1	sfn	PERSON
bptjm-56	82	1	3.4	CARDINAL
bptjm-56	82	2	rsv	ORG
bptjm-56	82	3	39	CARDINAL
bptjm-56	82	4	ammation39	GPE
bptjm-56	83	1	mmp-9	PERSON
bptjm-56	83	2	nlgn3	ORG
bptjm-56	83	3	nrxn1	GPE
bptjm-56	83	4	asd39	DATE
bptjm-56	84	1	microrna-155	ORG
bptjm-56	84	2	mir-15	WORK_OF_ART
bptjm-56	84	3	rsv	ORG
bptjm-56	84	4	ammation.29	PERSON
bptjm-56	85	1	rsv	ORG
bptjm-56	85	2	5	CARDINAL
bptjm-56	85	3	10	DATE
bptjm-56	85	4	15 mg/kg	QUANTITY
bptjm-56	85	5	berkeley pharma tech journal	ORG
bptjm-56	85	6	70	CARDINAL
bptjm-56	85	7	tnf-ɑ	PERSON
bptjm-56	85	8	0 hours, 8 hours	TIME
bptjm-56	85	9	18 hours	TIME
bptjm-56	85	10	rsv	ORG
bptjm-56	85	11	vpa	PERSON
bptjm-56	85	12	asd.37 vpa	PERSON
bptjm-56	85	13	asd.38 vpa	ORG
bptjm-56	85	14	rsv administration	ORG
bptjm-56	85	15	3.6 mg/kg	QUANTITY
bptjm-56	85	16	12-13 days	DATE
bptjm-56	85	17	model37	PERSON
bptjm-56	86	1	making37	PERSON
bptjm-56	87	1	interaction40	GPE
bptjm-56	89	1	vpa	PERSON
bptjm-56	89	2	rsv	ORG
bptjm-56	89	3	vpa exposure40	PERSON
bptjm-56	90	1	rsv	ORG
bptjm-56	90	2	20-40 mg	QUANTITY
bptjm-56	90	3	kg37	WORK_OF_ART
bptjm-56	92	1	ccr	ORG
bptjm-56	92	2	treatment37	ORG
bptjm-56	93	1	mmp	CARDINAL
bptjm-56	93	2	dysfunction39	GPE
bptjm-56	94	1	rsv	ORG
bptjm-56	94	2	berkeley pharma tech journal	ORG
bptjm-56	94	3	71	DATE
bptjm-56	94	4	anti-tnf	NORP
bptjm-56	95	1	rsv	ORG
bptjm-56	97	1	4	CARDINAL
bptjm-56	97	2	4.1	CARDINAL
bptjm-56	97	3	msc	PERSON
bptjm-56	98	1	mscs	ORG
bptjm-56	104	1	non-invasive42	LOC
bptjm-56	106	1	berkeley pharma tech journal	ORG
bptjm-56	106	2	72	CARDINAL
bptjm-56	106	3	diabetes42	ORG
bptjm-56	108	1	msc	PERSON
bptjm-56	109	1	mscs	ORG
bptjm-56	109	2	tumors42	ORG
bptjm-56	110	1	4.2	CARDINAL
bptjm-56	111	1	the past few decades	DATE
bptjm-56	111	2	one	CARDINAL
bptjm-56	117	1	berkeley pharma tech journal	ORG
bptjm-56	118	1	73	CARDINAL
bptjm-56	118	2	patterns25	GPE
bptjm-56	124	1	half	CARDINAL
bptjm-56	124	2	only around 20 minutes	TIME
bptjm-56	124	3	brain25	ORG
bptjm-56	127	1	4.3	CARDINAL
bptjm-56	127	2	sfn	CARDINAL
bptjm-56	128	1	sfn	PERSON
bptjm-56	129	1	berkeley pharma tech journal	ORG
bptjm-56	129	2	74	CARDINAL
bptjm-56	129	3	32	DATE
bptjm-56	129	4	33	DATE
bptjm-56	130	1	brussels	GPE
bptjm-56	131	1	sfn	ORG
bptjm-56	132	1	sfn	ORG
bptjm-56	134	1	asd43	ORG
bptjm-56	134	2	44	DATE
bptjm-56	135	1	autism8	GPE
bptjm-56	135	2	45	DATE
bptjm-56	135	3	46	DATE
bptjm-56	136	1	sfn	PERSON
bptjm-56	137	1	48	DATE
bptjm-56	138	1	sfn	PERSON
bptjm-56	139	1	medications33	GPE
bptjm-56	139	2	34	DATE
bptjm-56	143	1	sfn	PERSON
bptjm-56	144	1	berkeley pharma tech journal	ORG
bptjm-56	144	2	75	CARDINAL
bptjm-56	147	1	4.4	CARDINAL
bptjm-56	147	2	rsv	ORG
bptjm-56	148	1	rsv	ORG
bptjm-56	148	2	1%	PERCENT
bptjm-56	148	3	excreted49	ORG
bptjm-56	149	1	therapies49	ORG
bptjm-56	151	1	options31	ORG
bptjm-56	152	1	rsv	ORG
bptjm-56	152	2	abilities39	GPE
bptjm-56	153	1	rsv	ORG
bptjm-56	153	2	conditions50	GPE
bptjm-56	154	1	rsv for asd symptoms37	ORG
bptjm-56	155	1	rsv	ORG
bptjm-56	156	1	berkeley pharma tech journal	ORG
bptjm-56	156	2	76	DATE
bptjm-56	156	3	rsv	ORG
bptjm-56	156	4	japanese	NORP
bptjm-56	156	5	macaques37	PERSON
bptjm-56	157	1	nausea31	GPE
bptjm-56	162	1	5	CARDINAL
bptjm-56	162	2	msc	PERSON
bptjm-56	162	3	sfn	GPE
bptjm-56	162	4	one	CARDINAL
bptjm-56	164	1	one	CARDINAL
bptjm-56	167	1	msc	PERSON
bptjm-56	167	2	sfn	GPE
bptjm-56	168	1	berkeley pharma tech journal	ORG
bptjm-56	168	2	77	CARDINAL
bptjm-56	169	1	rsv	ORG
bptjm-56	171	1	6	CARDINAL
bptjm-56	171	2	recent years	DATE
bptjm-56	173	1	msc	PERSON
bptjm-56	177	1	msc	PERSON
bptjm-56	177	2	sfn	GPE
bptjm-56	178	1	berkeley pharma tech journal	ORG
bptjm-56	178	2	78	CARDINAL
bptjm-56	178	3	1	CARDINAL
bptjm-56	178	4	maenner mj	PERSON
bptjm-56	179	1	8 years	DATE
bptjm-56	179	2	11	CARDINAL
bptjm-56	179	3	united states	GPE
bptjm-56	179	4	2020	DATE
bptjm-56	180	1	mmwr surveill summ	PERSON
bptjm-56	181	1	2023;72(2):1-14	DATE
bptjm-56	183	1	2	CARDINAL
bptjm-56	183	2	hodges h	ORG
bptjm-56	183	3	fealko c	ORG
bptjm-56	183	4	soares n.	PERSON
bptjm-56	185	1	2020;9(suppl 1	DATE
bptjm-56	187	1	3.	CARDINAL
bptjm-56	187	2	faras h	ORG
bptjm-56	187	3	al ateeqi n	PERSON
bptjm-56	188	1	saudi	NORP
bptjm-56	189	1	2010;30(4):295-300	CARDINAL
bptjm-56	191	1	4	CARDINAL
bptjm-56	191	2	leclerc s	ORG
bptjm-56	191	3	easley d.	NORP
bptjm-56	192	1	2015;40(6):389	CARDINAL
bptjm-56	192	2	5	CARDINAL
bptjm-56	193	1	sharma sr	PERSON
bptjm-56	193	2	gonda x	PERSON
bptjm-56	195	1	2018;190:91-104	CARDINAL
bptjm-56	196	1	doi:10.1016	GPE
bptjm-56	197	1	6	CARDINAL
bptjm-56	197	2	wong	PERSON
bptjm-56	199	1	egypt	GPE
bptjm-56	199	2	j neurol psychiatry neurosurg	ORG
bptjm-56	200	1	2022;58:91	CARDINAL
bptjm-56	201	1	7	CARDINAL
bptjm-56	206	1	eissa	PERSON
bptjm-56	206	2	a.	PERSON
bptjm-56	206	3	a.	PERSON
bptjm-56	206	4	sadek	GPE
bptjm-56	210	1	doi:10.3389	ORG
bptjm-56	211	1	9	CARDINAL
bptjm-56	211	2	noriyoshi et al	PERSON
bptjm-56	212	1	j mol sci	PERSON
bptjm-56	213	1	2023;24(6):5487	DATE
bptjm-56	215	1	10	CARDINAL
bptjm-56	216	1	hughes	ORG
bptjm-56	216	2	hk et al	PERSON
bptjm-56	217	1	behav immun	PERSON
bptjm-56	218	1	2023;108:245-254	CARDINAL
bptjm-56	219	1	doi:10.1016	GPE
bptjm-56	220	1	11	DATE
bptjm-56	221	1	das, m., mayilsamy	ORG
bptjm-56	221	2	k.	PERSON
bptjm-56	221	3	mohapatra	PERSON
bptjm-56	221	4	ss	ORG
bptjm-56	221	5	mohapatra	GPE
bptjm-56	221	6	s. mesenchymal	PERSON
bptjm-56	222	1	rev neurosci	PERSON
bptjm-56	223	1	855	CARDINAL
bptjm-56	225	1	liang	PERSON
bptjm-56	225	2	duan et al	PERSON
bptjm-56	226	1	bio mater	PERSON
bptjm-56	227	1	2020;3(9):6384-6393	DATE
bptjm-56	229	1	13	CARDINAL
bptjm-56	230	1	spiers jg	PERSON
bptjm-56	230	2	hill af	PERSON
bptjm-56	232	1	2022;24(4):385-391	CARDINAL
bptjm-56	234	1	villoslada p	ORG
bptjm-56	237	1	2004;146:403-414	CARDINAL
bptjm-56	238	1	berkeley pharma tech journal	ORG
bptjm-56	238	2	79 doi:10.1016	QUANTITY
bptjm-56	239	1	maclean ag	ORG
bptjm-56	239	2	philipp mt	PERSON
bptjm-56	241	1	2013;2013:480739	CARDINAL
bptjm-56	242	1	16	CARDINAL
bptjm-56	243	1	ooi yy	PERSON
bptjm-56	243	2	dheen st	PERSON
bptjm-56	244	1	sam wah tay s. paracrine e�	PERSON
bptjm-56	246	1	2015;22(4):233-242	CARDINAL
bptjm-56	247	1	17	DATE
bptjm-56	248	1	zhang y, liu m	PERSON
bptjm-56	250	1	2013;11:196	CARDINAL
bptjm-56	251	1	5876-11	DATE
bptjm-56	252	1	sun jm	PERSON
bptjm-56	257	1	ross da.	PERSON
bptjm-56	260	1	2017;81(3	CARDINAL
bptjm-56	261	1	1.004 20	CARDINAL
bptjm-56	262	1	mehdi sf	PERSON
bptjm-56	262	2	khenhrani rr	PERSON
bptjm-56	265	1	2022;13	ORG
bptjm-56	266	1	07 21	DATE
bptjm-56	267	1	clodi m	PERSON
bptjm-56	267	2	vila g	PERSON
bptjm-56	269	1	american journal of physiology-endocrinology	ORG
bptjm-56	270	1	2008;295(3	TIME
bptjm-56	272	1	gonzalez	PERSON
bptjm-56	274	1	london	GPE
bptjm-56	275	1	2022;377(1858):20210059	CARDINAL
bptjm-56	276	1	23	CARDINAL
bptjm-56	277	1	l.-l.	GPE
bptjm-56	277	2	n.	ORG
bptjm-56	280	1	2016	DATE
bptjm-56	281	1	24	CARDINAL
bptjm-56	282	1	peñagarikano o,	ORG
bptjm-56	282	2	mt	GPE
bptjm-56	282	3	lu xh	PERSON
bptjm-56	282	4	cntnap2	PRODUCT
bptjm-56	284	1	25	DATE
bptjm-56	285	1	kong xj	PERSON
bptjm-56	285	2	liu j	PERSON
bptjm-56	285	3	liu k	PERSON
bptjm-56	287	1	2021;13(5):1552	CARDINAL
bptjm-56	288	1	26	CARDINAL
bptjm-56	289	1	yatawara cj	PERSON
bptjm-56	289	2	einfeld sl	PERSON
bptjm-56	289	3	hickie ib	PERSON
bptjm-56	289	4	davenport ta	PERSON
bptjm-56	289	5	guastella aj	PERSON
bptjm-56	292	1	2015;21(9):1225-1231	DATE
bptjm-56	293	1	27	CARDINAL
bptjm-56	294	1	sikich l	ORG
bptjm-56	295	1	berkeley pharma tech journal	ORG
bptjm-56	295	2	80	CARDINAL
bptjm-56	296	1	new england journal of medicine	ORG
bptjm-56	297	1	2021;385(16):1462-1473	DATE
bptjm-56	298	1	28	CARDINAL
bptjm-56	299	1	devi kp	PERSON
bptjm-56	301	1	2019:271	CARDINAL
bptjm-56	302	1	0	CARDINAL
bptjm-56	303	1	ma q. role	PERSON
bptjm-56	303	2	nrf2	PERSON
bptjm-56	304	1	annual	DATE
bptjm-56	305	1	2013;53(1):401	CARDINAL
bptjm-56	306	1	30	CARDINAL
bptjm-56	307	1	ahmad sf	PERSON
bptjm-56	307	2	al-harbi	PERSON
bptjm-56	308	1	nrf2 activator	PERSON
bptjm-56	308	2	th17	PRODUCT
bptjm-56	310	1	2019;364:213-224	CARDINAL
bptjm-56	312	1	singh k	PERSON
bptjm-56	312	2	macklin ea	ORG
bptjm-56	313	1	the national academy of sciences	ORG
bptjm-56	314	1	2014;111(43):15550-15555	CARDINAL
bptjm-56	315	1	32	CARDINAL
bptjm-56	316	1	amirimoghaddam-yazdi z	PERSON
bptjm-56	316	2	moghaddam hs	PERSON
bptjm-56	316	3	mohammadi mr	PERSON
bptjm-56	316	4	akhondzadeh s.	PERSON
bptjm-56	318	1	2020;74(7):398	CARDINAL
bptjm-56	319	1	doi:10.1111	ORG
bptjm-56	320	1	smith rc	PERSON
bptjm-56	320	2	rh	ORG
bptjm-56	323	1	2022	CARDINAL
bptjm-56	325	1	magner m	PERSON
bptjm-56	325	2	thorová k	PERSON
bptjm-56	328	1	35	CARDINAL
bptjm-56	329	1	singh k	PERSON
bptjm-56	331	1	2021;12(1	CARDINAL
bptjm-56	333	1	liu h, zimmerman aw	PERSON
bptjm-56	333	2	singh k	PERSON
bptjm-56	335	1	2020;10(1	ORG
bptjm-56	336	1	doi:10.1038	ORG
bptjm-56	337	1	malaguarnera m	FAC
bptjm-56	338	1	basel	GPE
bptjm-56	338	2	switzerland	GPE
bptjm-56	340	1	38	CARDINAL
bptjm-56	344	1	2021;137:111322	CARDINAL
bptjm-56	344	2	doi:10.1016	GPE
bptjm-56	344	3	39	CARDINAL
bptjm-56	345	1	bhandari r	PERSON
bptjm-56	345	2	kuhad a. resveratrol	PERSON
bptjm-56	345	3	berkeley pharma tech journal	ORG
bptjm-56	345	4	81	CARDINAL
bptjm-56	347	1	2017;8-23	CARDINAL
bptjm-56	349	1	hirsch mm	PERSON
bptjm-56	350	1	microrna	ORG
bptjm-56	352	1	2018;115:336-343	CARDINAL
bptjm-56	354	1	fontes-dutra m	PERSON
bptjm-56	355	1	de oliveira	PERSON
bptjm-56	355	2	da rosa borges m	PERSON
bptjm-56	358	1	42	CARDINAL
bptjm-56	359	1	liu q	PERSON
bptjm-56	359	2	chen mx	PERSON
bptjm-56	359	3	sun l	ORG
bptjm-56	361	1	2019;11(2):55-72	DATE
bptjm-56	362	1	43	CARDINAL
bptjm-56	363	1	mcguinness g	PERSON
bptjm-56	363	2	kim y.	PERSON
bptjm-56	368	1	liu x	PERSON
bptjm-56	368	2	lin j	PERSON
bptjm-56	368	3	zhang h	PERSON
bptjm-56	370	1	2022;13:813304	CARDINAL
bptjm-56	370	2	45	CARDINAL
bptjm-56	371	1	houghton	PERSON
bptjm-56	373	1	2019;2019:2716870	CARDINAL
bptjm-56	374	1	46	DATE
bptjm-56	375	1	johnson rw	PERSON
bptjm-56	375	2	nrf2	PERSON
bptjm-56	377	1	2016;73:42-48	CARDINAL
bptjm-56	377	2	doi:10.1016	GPE
bptjm-56	378	1	riedl ma	PERSON
bptjm-56	378	2	diaz-sanchez	PERSON
bptjm-56	379	1	clin immunol	PERSON
bptjm-56	380	1	2009;130(3):244	CARDINAL
bptjm-56	381	1	doi:10.1016	GPE
bptjm-56	381	2	48	DATE
bptjm-56	382	1	wen h	GPE
bptjm-56	382	2	yang hj	PERSON
bptjm-56	383	1	mcp	PERSON
bptjm-56	383	2	2013;12(3):575-586	CARDINAL
bptjm-56	384	1	49	DATE
bptjm-56	385	1	moussa	PERSON
bptjm-56	385	2	turner rs	PERSON
bptjm-56	387	1	the new york academy of sciences	ORG
bptjm-56	390	1	malaguarnera l.	PERSON
bptjm-56	392	1	2019;11(5):946	CARDINAL
bptjm-56	393	1	berkeley pharma tech journal	ORG
bptjm-56	393	2	82	CARDINAL
bptjm-56	393	3	56	CARDINAL
bptjm-56	393	4	paper-573-1-11-20240510	TIME
bptjm-56	393	5	1).pdf	CARDINAL